550 Hills Drive 3rd Floor
Bedminster, NJ 07921
www.npsp.com
Public
NASDAQ:NPSP
 Synopsis: Business Condition
Year Founded 1986
Employment 63
Sector N/A
Industry N/A
NPS Pharmaceuticals Inc
     Last modified on: 2013-01-11

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of specialty therapeutics for gastrointestinal and endocrine disorders. The company is advancing two late-stage programs to restore or replace biological function, including GATTEX (teduglutide), which is in Phase 3 clinical development for parenteral dependent short bowel syndrome; and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) that is in Phase 3 clinical development as a hormone therapy for hypoparathyroidism. It complements its internal programs with strategic partnerships with Amgen, GlaxoSmithKline, Kyowa Kirin, and Nycomed. The company was founded in 1986 and is headquartered in Bedminster, New Jersey.